Women experience more GLP-1 side effects

Women are more likely to experience adverse events from GLP-1 medications. Research indicates women may be overmedicated due to slower drug clearance, leading to higher rates of side effects like nausea and dizziness. Clinical trials often underrepresent women, hindering the understanding of sex-specific drug responses. This disparity highlights the need for sex-stratified research to personalize treatments and improve patient outcomes, especially as GLP-1s are used for various conditions.